Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT07382297

Effect of Adding Ultrasound Guided IPACK Block to Adductor Canal Block for Postoperative Pain in Knee Tumor Excision

Led by National Cancer Institute, Egypt · Updated on 2026-02-02

70

Participants Needed

1

Research Sites

45 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

the aim of this study is to determine the analgesic effect of iPACK in combination to ACB after the excision of tumors around the Knee regarding the following: * Time to the 1st rescue analgesia. * Postoperative morphine consumption. * Postoperative visual analogue scale (VAS). This study will include patients, aged 18 to 65 years, belonging to the American Society of Anesthesiologists (ASA) physical status II to IV , undergoing excision of tumors around the knee under spinal anesthesia. Patients will be randomly allocated Group iPACK plus Adductor canal block (ACB) : patients will receive ACB plus iPACK block. • Control group : patients will not receive any block but will take morphine 3mg bolus at VAS more than 4 and regular NSAIDS and paracetamol iv.

CONDITIONS

Official Title

Effect of Adding Ultrasound Guided IPACK Block to Adductor Canal Block for Postoperative Pain in Knee Tumor Excision

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Willingness to follow all study procedures and be available for the entire study period
  • American Society of Anesthesiologists (ASA) physical status II to IV
  • Scheduled for excision of tumors around the knee under spinal anesthesia
  • Aged between 18 and 65 years
Not Eligible

You will not qualify if you...

  • Patient refusal to participate
  • Presence of neuromuscular disorders
  • Allergy to local anesthetics
  • History of previous knee surgery
  • History of prior knee infection
  • Contraindications to spinal anesthesia such as coagulopathies or severe aortic stenosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National cancer institute

Cairo, Egypt, 11769

Actively Recruiting

Loading map...

Research Team

N

Norma Osama Abdallah Zayed, MD

CONTACT

F

Fady Attef, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here